|
It is not a secret that over the past four decades, RA research has often been driven by the pharmaceutical industry rather than researchers. This was particularly so in the 1970s-80s, with a focus on NSAIDs - drugs which do not alter the course of RA at all. The same mistake was repeated with anti-rheumatic drugs - researching combinations of often expensive drugs to achieve minor goals. And then again, the infamous COX-2 drugs represented by Vioxx - causing more harm than benefit.
Isn't it time to accept the fact that it has been a total failure in attempting to control inflammatory arthritis? Isn't it time to alter the goal of RA research from CONTROL to CURE?
From a broader perspective, this is not just an isolated problem in RA research. Current medicine research typically places its emphasis on suppressing symptoms of a disease rather than addressing the root cause of those symptoms. Patients often end up taking more drugs to counter the side effects of other drugs.
In order to create more effective treatment for RA, researchers must completely change the way they understand diseases. It's totally unnecessary to create more sophisticated names for different combination of symptoms. There are already too many "diseases" for doctors to spell and pronounce.
As the Chinese discovered four thousand years ago, "if you don't find the disease in youngsters, it's about weak metabolism."
Rheumatoid Arthritis is one of those diseases. You don't find RA in children very often. Yes, some children develop juvenile rheumatoid arthritis (JRA). But just as unusual as they have JRA, their bone, joint and muscle metabolisms are unusually slower than that of a normal kid. This is evidenced by the proven effectiveness of EZorb against JRA.
Rheumatoid arthritis, just like osteoarthritis, is linked to weakened bone, joint and muscle metabolism, which also causes bone spur, bone loss and many other musculoskeletal disorders.
The only effective way to correct all those diseases is to go to the source of the problem by raising bone, joint and muscle metabolism. EZorb does exactly that.
In average it takes about 6-12 weeks for RA patients to notice the improvement once they start taking EZorb. Pain level reduces continuously as the healing process goes on. Thousands RA patients have used EZorb to their satisfaction. Many have since returned to their previous life style.
|
autoimmune disease in which the body's defense system responds to a "false alarm" and attacks the joints. Different opinions center on which part of the joint is involved. Some believe that the synovium is attacked. Others argue that the collagen is assaulted. None of the argument really matters because the cause of the disease remains unknown to researchers.
